A dielectric nanolubricant composition is provided. The dielectric nanolubricant composition includes a nano-engineered lubricant additive dispersed in a base. The nano-engineered lubricant additive may include a plurality of solid lubricant nanostructures having an open-ended architecture and an organic, inorganic, and/or polymeric medium intercalated in the nanostructures and/or encapsulate nanostructures. The base may include a grease or oil such as silicone grease or oil, lithium complex grease, lithium grease, calcium sulfonate grease, silica thickened perfluoropolyether (PFPE) grease or PFPE oil, for example. This dielectric nanolubricant composition provides better corrosion and water resistance, high dielectric strength, longer material life, more inert chemistries, better surface protection and asperity penetration, no curing, no staining, and environmentally friendly, compared to current products in the market.

A particle and a composition including a plurality of particles are provided, wherein the particles are platelets exhibiting a planar geometry which is circular or which is made up of a number (x) of planar (y)-sided polygon(s), wherein x is from 1 to 20 and y is at least 3 wherein if x is greater than 1 then said planar (y)-sided polygons are fused along one or more sides thereof, wherein the width (W.sub.P) of the platelets (P) at their widest point is no more than about 250 pm and the thickness of the platelets (P) is in the range of 10 nm to 50 nm.

The invention provides highly concentrated chitosan-nucleic acid polyplex compositions and dispersions, and methods for producing the compositions and dispersions. Methods of mixing the chitosan-nucleic acid polyplexes include an inline mixing of chitosan solution and nucleic acid solution, followed by further concentrating the dispersion of chitosan-nucleic acid polyplexes, optionally with an aggregation inhibitor. Further provides are methods for altering the diameter of chitosan-nucleic acid polyplexes.

A flue gas additive is provided that includes both a nitrogenous component to reduce gas phase nitrogen oxides and a halogen-containing component to oxidize gas phase elemental mercury.

An apparatus and process for creating uniformly sized, spherical nanoparticles from a solid target. The solid target surface is ablated to create an ejecta event containing nanoparticles moving away from the surface. Ablation may be caused by laser or electrostatic discharge. At least one electromagnetic field is placed in front of the solid target surface being ablated. The electromagnetic field manipulates at least a portion of the nanoparticles as they move away from the target surface through the electromagnetic field to increase size and spherical shape uniformity of the nanoparticles. The manipulated nanoparticles are collected.

The amorphous inorganic anion exchanger of the present invention is represented by Formula (1) and has an average primary particle size observed with an electron microscope of at least 1 nm but no greater than 500 nm and an NO.sub.3 content of no greater than 1 wt % of the whole:
BiO(OH)  Formula (1).

This invention relates to strontium-phosphate microparticles that incorporate radioisotopes for radiation therapy and imaging.

A method for surface treatment of a metal material in a powder state is provided, the method including obtaining a powder formed from a plurality of particles of the metal material to be treated; and subjecting the powder to an ion implantation process by directing a beam of singly-charged or multi-charged ions towards an outer surface of the particles, the beam being produced by a source of singly-charged or multi-charged ions, whereby the particles have an overall spherical shape with a radius (R). There is also provided a material in a powder state formed from a plurality of particles having a ceramic outer layer and a metal core, the particles having an overall spherical shape.

1-[2-(2,4-dimethylphenylsulphanyl)phenyl)]piperazine exhibits potent activity on SERT, 5-HT.sub.3 and 5-HT.sub.1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.

The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.